Про- вакс - дилърите няма да останат без работа, макар най-кресливите от тях да имат друга тема на дневен ред
Burton said Covid will likely follow a seasonal pattern like other well-known respiratory viruses such as the flu. Although a majority of the population will not be susceptible to severe disease, the virus will still cause sickness and death among the vulnerable. CEO Stephane Bancel said people older than 50 and those with health conditions will still need to get vaccinated against Covid. Key markets are already preparing for annual boosters, he said.
“Some countries like the U.K. and others wanted to secure supply because they believe very deeply that the endemic market will require annual boosters,” Bancel told analysts during the company’s earnings call.
Bancel also noted that Moderna’s $19 billion sales projection for this year doesn’t include any orders from the U.S., which receives its last shipment in April and hast not signed a contract for the fall. Moderna also has $3 billion in vaccine order options on top of its already signed agreements.
Bancel said he expects a substantial portion of those options to be exercised by governments regardless of whether a new variant emerges, which could bring the company’s 2022 guidance to at least $22 billion, not including any possible U.S. orders.
Children in the U.S. are not yet eligible for Moderna’s vaccine. Moderna’s shot for teenagers ages 12- to 17-years-old is currently under review by the FDA. The company is waiting to file an application with the FDA to authorize its vaccine for 6- to 11-year-olds until after the shots for teenagers get cleared.
Moderna expects data on the vaccine for children 5-years-old and younger this month.
https://www.cnbc.com/2022/03/03/covi...this-year.html
Burton said Covid will likely follow a seasonal pattern like other well-known respiratory viruses such as the flu. Although a majority of the population will not be susceptible to severe disease, the virus will still cause sickness and death among the vulnerable. CEO Stephane Bancel said people older than 50 and those with health conditions will still need to get vaccinated against Covid. Key markets are already preparing for annual boosters, he said.
“Some countries like the U.K. and others wanted to secure supply because they believe very deeply that the endemic market will require annual boosters,” Bancel told analysts during the company’s earnings call.
Bancel also noted that Moderna’s $19 billion sales projection for this year doesn’t include any orders from the U.S., which receives its last shipment in April and hast not signed a contract for the fall. Moderna also has $3 billion in vaccine order options on top of its already signed agreements.
Bancel said he expects a substantial portion of those options to be exercised by governments regardless of whether a new variant emerges, which could bring the company’s 2022 guidance to at least $22 billion, not including any possible U.S. orders.
Children in the U.S. are not yet eligible for Moderna’s vaccine. Moderna’s shot for teenagers ages 12- to 17-years-old is currently under review by the FDA. The company is waiting to file an application with the FDA to authorize its vaccine for 6- to 11-year-olds until after the shots for teenagers get cleared.
Moderna expects data on the vaccine for children 5-years-old and younger this month.
https://www.cnbc.com/2022/03/03/covi...this-year.html
Кой разбрал - разбрал. 
Коментар